Skip to main content
Genmab logo

Genmab — Investor Relations & Filings

Ticker · GMAB ISIN · DK0010272202 LEI · 529900MTJPDPE4MHJ122 CO Manufacturing
Open in API
Filings indexed 2,826 across all filing types
Latest filing 2026-05-29 Director's Dealing
Country DK Denmark
Listing CO GMAB

About Genmab

https://www.genmab.com/

Genmab is an international biotechnology company that specializes in the creation, development, and commercialization of differentiated antibody therapeutics. The company focuses on transforming the treatment of cancer and other serious diseases. By utilizing proprietary antibody technology platforms and scientific expertise, Genmab develops a pipeline of innovative medicines. Its activities span from discovery and research through clinical development to deliver novel therapies to patients.

Recent filings

Filing Released Lang Actions
Transactions with Shares and Linked Securities in Genmab A/S Made by Managerial Employees and Their Closely Associated Persons
Director's Dealing Classification · 93% confidence The document is a company announcement disclosing share transactions by managerial employees and their closely associated persons under Article 19 of the EU Market Abuse Regulation. It details the sale of Genmab shares by a board member, including transaction date, price, volume, and legal entity identifiers. This matches the definition of a Director’s Dealing report (insider trades).
2026-05-29 English
Transactions with Shares and Linked Securities in Genmab A/S Made by Managerial Employees and Their Closely Associated Persons
Director's Dealing Classification · 95% confidence The document is a company announcement disclosing share transactions by managerial employees and their closely associated persons under Article 19 of EU Market Abuse Regulation. This is a typical insider transaction (director dealings) disclosure, matching the Director’s Dealing category.
2026-05-29 English
6-K
Director's Dealing Classification · 95% confidence The document is a Form 6-K (report of a foreign private issuer) whose Exhibit 99.1 is a “Company Announcement … Transactions with Shares and Linked Securities in Genmab A/S Made by Managerial Employees and Their Closely Associated Persons.” This is a disclosure of insider share transactions by directors/executives, matching the definition of Director’s Dealing (DIRS).
2026-05-29 English
6-K - GENMAB A/S (0001434265) (Filer)
Regulatory Filings Classification · 90% confidence The document is a Form 6-K filed with the U.S. SEC by a foreign private issuer, serving as a regulatory submission under the Securities Exchange Act. It is neither an annual nor interim financial report nor a proxy or dividend notice; it is a general SEC regulatory filing, fitting the Regulatory Filings category.
2026-05-13 English
6-K - GENMAB A/S (0001434265) (Filer)
Regulatory Filings Classification · 84% confidence The document is a Form 6-K filed by Genmab A/S— a periodic report of a foreign private issuer under the Securities Exchange Act. There is no specific category for Form 6-K in the taxonomy, so it falls under the general category for regulatory announcements and compliance documents (Regulatory Filings).
2026-05-12 English
Capital Increase in Genmab as a Result of Employee Warrant Exercise
Share Issue/Capital Change Classification · 93% confidence The document is a Company Announcement detailing the terms and effects of a share capital increase following the exercise of employee warrants, including number of new shares, subscription prices, and updated nominal share capital. This is a direct announcement of a change in the company’s capital structure (new share issuance). It does not present a full financial report, earnings release, or AGM materials, nor is it a mere publication notice. It fits the definition of "Share Issue/Capital Change" (Code: SHA).
2026-05-12 English

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.